Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma

A differentiation antigen commonly expressed on melanoma cells, gp100 is the target of infiltrating T cells. We conducted a phase I randomized cross-over trial of melanoma patients with either xenogeneic (mouse) or human gp100 plasmid DNA injected intramuscularly at three dosages (100, 500 or 1,500 ...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Yuan, Jianda, Ku, Geoffrey Y., Gallardo, Humilidad F., Orlandi, Francesca, Manukian, Gregor, Rasalan, Teresa S., Xu, Yinyan, Li, Hao, Vyas, Shachi, Mu, Zhenyu, Chapman, Paul B., Krown, Susan E., Panageas, Katherine, Terzulli, Stephanie L., Old, Lloyd J., Houghton, Alan N., Wolchok, Jedd D.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Academy of Cancer Immunology 2009
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2888533/
https://ncbi.nlm.nih.gov/pubmed/19496531
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items